Efavirenz Metabolite D-d4 (Major) |
|
Synonyms: rac 7-Hydroxy Efavirenz-d4 (Major); 6-Chloro-4-(cyclopropyl-d4-ethynyl)-1,4-dihydro-7-hydroxy-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one | |
Cat. No.: E21101 | CAS No.: 1189857-89-3 |
MDL.: | Formula: C14H5D4ClF3NO3 |
F.W.335.7 | Purity: 99% |
Storage: -20°C Freezer | |
  |

Catalog Number: | E21101 | CAS No.: | 1189857-89-3 | |
MDL: | Formula: | C14H5D4ClF3NO3 | ||
F.W.: | 335.7 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | Off-White Solid | M.P.: | >194°C (dec.) | |
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | DMSO, Ethyl Actetae, Methanol | Stability: | ||
Storage: | -20°C Freezer | Category: | Reference Standard | |
Reference: | Gorski, J., et al.: Biochem. Pharmacol., 47, 1643 (1994), Desta, Z., et al.: J. Pharmacol. Exp. Ther., 285, 428 (1998), Langmann, P., et al.: Eur. J. Med. Res., 7, 309 (2002), Chang, T., et al.: Drug Metab. Dispos., 31, 7 (2003), | |||
Application: | An isotope labelled metabolite of Efavirenz(minor). A representative lot was 84% d4, 12% d5, 2% d3 and 1% d6. | |||
Category: | Isotope Labelled Compounds, Metabolites & Impurities, Non-nucleoside Reverse Transcriptase, |